13 March 2024 - NICE has published final evidence-based recommendations on the use of fluocinolone acetonide intravitreal implant (Iluvien) for adults with visual impairment.

Fluocinolone acetonide intravitreal implant is recommended as an option for the treatment of adults with visual impairment caused by chronic diabetic macular oedema that has not responded well enough to available treatments.

Read NICE technology appraisal guidance